Ernexa Therapeutics, Inc. (ERNA)
1.36
-0.27
(-16.56%)
USD |
NASDAQ |
Nov 20, 16:00
1.41
+0.05
(+3.68%)
After-Hours: 20:00
Ernexa Therapeutics Price : 1.36 for Nov. 20, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2026 | 1.60 | 1.60 | 1.35 | 1.36 | 20384.00 |
| Nov 19, 2026 | 1.62 | 1.704 | 1.560 | 1.63 | 12363.00 |
| Nov 18, 2026 | 1.64 | 1.712 | 1.60 | 1.62 | 14754.00 |
| Nov 17, 2026 | 1.65 | 1.822 | 1.57 | 1.63 | 26221.00 |
| Nov 16, 2026 | 1.80 | 1.80 | 1.69 | 1.69 | 20359.00 |
| Nov 13, 2026 | 1.82 | 1.94 | 1.67 | 1.68 | 28254.00 |
| Nov 12, 2026 | 1.87 | 2.04 | 1.734 | 1.79 | 23993.00 |
| Nov 11, 2026 | 2.053 | 2.053 | 1.90 | 1.93 | 9816.00 |
| Nov 10, 2026 | 1.98 | 2.04 | 1.90 | 2.01 | 13422.00 |
| Nov 09, 2026 | 1.87 | 2.05 | 1.754 | 2.05 | 28403.00 |
| Nov 06, 2026 | 1.78 | 1.895 | 1.78 | 1.88 | 7914.00 |
| Nov 05, 2026 | 2.05 | 2.05 | 1.74 | 1.83 | 33733.00 |
| Nov 04, 2026 | 1.98 | 2.04 | 1.94 | 1.99 | 17333.00 |
| Nov 03, 2026 | 2.075 | 2.123 | 1.99 | 2.02 | 11374.00 |
| Nov 02, 2026 | 2.04 | 2.04 | 1.93 | 1.95 | 8999.00 |
| Oct 30, 2026 | 2.08 | 2.14 | 1.95 | 1.97 | 4493.00 |
| Oct 29, 2026 | 2.03 | 2.11 | 1.998 | 2.11 | 7267.00 |
| Oct 28, 2026 | 1.91 | 2.030 | 1.91 | 1.98 | 3540.00 |
| Oct 27, 2026 | 2.12 | 2.12 | 1.96 | 1.993 | 7462.00 |
| Oct 26, 2026 | 1.98 | 2.08 | 1.92 | 1.938 | 11182.00 |
| Oct 23, 2026 | 2.075 | 2.09 | 2.03 | 2.065 | 5931.00 |
| Oct 22, 2026 | 2.095 | 2.125 | 1.98 | 2.075 | 16467.00 |
| Oct 21, 2026 | 2.19 | 2.255 | 2.08 | 2.11 | 9569.00 |
| Oct 20, 2026 | 1.96 | 2.260 | 1.89 | 2.24 | 48187.00 |
| Oct 19, 2026 | 2.04 | 2.07 | 1.839 | 1.98 | 44353.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cerenome, Inc. | 0.6301 |
| ACADIA Pharmaceuticals, Inc. | 17.11 |
| Alnylam Pharmaceuticals, Inc. | 143.82 |
| Anika Therapeutics, Inc. | 13.23 |
| Savara, Inc. | 4.26 |
Price Related Metrics
| Price to Book Value | 0.5143 |
| Earnings Yield | -1.25K% |
| Market Cap | 2.237M |